Masimo/$MASI
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Masimo
Masimo Corp is a technology company. The company's segment includes healthcare and non-healthcare. The healthcare business segment is a key revenue driver, develops, manufactures, and markets a variety of noninvasive patient monitoring technologies, hospital automation and connectivity solutions, remote monitoring devices and consumer health products. Its non-healthcare segment includes consumer audio business develops, manufactures, markets sells and licenses premium and luxury audio sound products and related integration technologies.
Ticker
$MASI
Sector
Primary listing
Industry
Health Care Equipment & Supplies
Headquarters
Employees
3,600
ISIN
US5747951003
Website
Masimo Metrics
BasicAdvanced
$9B
-
-$9.23
1.19
-
Price and volume
Market cap
$9B
Beta
1.19
52-week high
$194.88
52-week low
$101.61
Average daily volume
631K
Financial strength
Current ratio
2.167
Quick ratio
0.763
Long term debt to equity
67.202
Total debt to equity
67.202
Interest coverage (TTM)
1.34%
Profitability
EBITDA (TTM)
133
Gross margin (TTM)
48.51%
Net profit margin (TTM)
-23.25%
Operating margin (TTM)
2.60%
Effective tax rate (TTM)
-4.09%
Revenue per employee (TTM)
$590,000
Management effectiveness
Return on assets (TTM)
1.32%
Return on equity (TTM)
-25.07%
Valuation
Price to revenue (TTM)
4.188
Price to book
9.53
Price to tangible book (TTM)
11.45
Price to free cash flow (TTM)
64.916
Free cash flow yield (TTM)
1.54%
Free cash flow per share (TTM)
256.21%
Growth
Revenue change (TTM)
16.68%
Earnings per share change (TTM)
-729.78%
3-year revenue growth (CAGR)
19.56%
10-year revenue growth (CAGR)
13.56%
3-year earnings per share growth (CAGR)
33.61%
10-year earnings per share growth (CAGR)
21.80%
What the Analysts think about Masimo
Analyst ratings (Buy, Hold, Sell) for Masimo stock.
Bulls say / Bears say
Masimo's Q1 2025 earnings per share of $1.36 surpassed the Zacks Consensus Estimate of $1.24, marking a 9.68% earnings surprise. (finviz.com)
The company announced the sale of its consumer audio division to Harman International for $350 million, allowing Masimo to focus more on its core healthcare business. (stockanalysis.com)
Masimo's stock surged by 11.04% following strong Q4 2024 results, with a 9% year-over-year increase in sales driven by robust demand for its medical technology products. (gurufocus.com)
Masimo's stock dropped 24% after announcing preliminary Q2 revenue of $453 million to $457 million, significantly below Wall Street's expectation of $540.87 million. (benzinga.com)
The company faced a legal setback when the U.S. International Trade Commission ruled that Apple Watches violated Masimo's patent rights, leading to a ban on certain Apple Watch imports. (reuters.com)
Masimo's CEO Joe Kiani resigned following a proxy battle, leading to potential uncertainties in leadership and strategic direction. (en.wikipedia.org)
Data summarised monthly by Lightyear AI. Last updated on 10 Jul 2025.
Masimo Financial Performance
Revenues and expenses
Masimo Earnings Performance
Company profitability
Masimo News
AllArticlesVideos
MASIMO CORPORATION INVESTIGATION ALERT: Johnson Fistel, PLLP Investigates Potential Breach of Fiduciary Duties by Masimo Officers and Directors
GlobeNewsWire·2 weeks ago
MASI INVESTIGATION ALERT: Johnson Fistel PLLP Investigates the Directors and Officers of Masimo Corporation for Breach of Fiduciary Duties
GlobeNewsWire·1 month ago
MASI INVESTIGATION ALERT: Johnson Fistel PLLP Investigates the Directors and Officers of Masimo Corporation for Breach of Fiduciary Duties
Business Wire·1 month ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Masimo stock?
Masimo (MASI) has a market cap of $9B as of July 11, 2025.
What is the P/E ratio for Masimo stock?
The price to earnings (P/E) ratio for Masimo (MASI) stock is 0 as of July 11, 2025.
Does Masimo stock pay dividends?
No, Masimo (MASI) stock does not pay dividends to its shareholders as of July 11, 2025.
When is the next Masimo dividend payment date?
Masimo (MASI) stock does not pay dividends to its shareholders.
What is the beta indicator for Masimo?
Masimo (MASI) has a beta rating of 1.19. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.